Coronavirus guidance by subject
Midlands and Lancashire Commissioning Support Unit
The list of resources will be updated as new material becomes available so please check back regularly for updates.
This page groups the resources by subject matter. The same list of resources is also available grouped by the organisation that issued it.
Latest
Thu 21 May Anticoagulation in cancer (RDTC guidance adopted by MLCSU)
Thu 21 May Depot antipsychotic injections: Administration during COVID-19 in stable adult patients (MLCSU)
Thu 21 May Pharmacy and Medicines Support to Care Homes: Urgent System-Wide Delivery Model (SPS)
Thu 21 May Care Home Resource Hub (SPS)
Thu 21 May Coronavirus (COVID-19): support for care homes (DHSC)
Thu 21 May COVID-19 response: Identifying a clinical lead for all care homes (NHSEI)
Thu 21 May MHRA regulatory flexibilities resulting from coronavirus (COVID-19)
Mon 18 May Organisational Prescribing Code and EPS Guide for Primary Care (NHS North West)
Mon 18 May Risks Assessment and Considerations – for setting up COVID-19 Hubs (NHS North West)
Mon 18 May COVID-19 Supporting Guidance for prescribers working within COVID hubs and Medicine Conveyance with GP bags (NHS North West)
Therapeutic areas
Prescribing guidance
Operational guidance
Therapeutic areas
Anti-infective
- Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19 (NHSEI)
- Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (NICE, ES23)
- Asthma and COPD - oral steroid or antibiotic 'rescue packs' and extra steroid inhalers (RDTC guidance adopted by MLCSU)
- Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment (MHRA)
- Coronavirus - COVID 19 (CKS)
- Early use of antibiotics in high-risk patients (under revew for MLCSU position)
- Managing coronavirus (COVID-19) in general practice (SOP) (NHSEI)
- Notifiable diseases and causative organisms: how to report (PHE)
- Prescribing antibiotics for urgent dental care during sustained transmission of COVID 19 (BDA)
- Vitamin D and infection risk (RDTC guidance adopted by MLCSU)
Blood and blood-forming organs
- COVID-19 updates (British Society for Haematology)
- Vitamin B12 replacement (MLCSU)
Cardiovascular system
- Anticoagulation in cancer (RDTC guidance adopted by MLCSU)
- Coronavirus (COVID-19) and high blood pressure medication (MHRA)
- Coronavirus and you (British Heart Foundation)
- COVID-19 Clinicians Resource Hub (British Cardiovascular Society)
- Management of patients currently on warfarin during COVID-19 (SPS guidance adopted by MLCSU)
- Monitoring direct acting oral anticoagulants (DOACs) during the COVID-19 pandemic (RDTC guidance adopted by MLCSU)
- Practical guidance for patients infected with COVID-19 (Thrombosis UK)
Endocrine system
- Coronavirus and diabetes (Diabetes UK)
- COVID-19 and diabetes (Primary Care Diabetes Society)
- Prescribing in diabetes (RDTC guidance adopted by MLCSU)
Genito-urinary system
- Coronavirus (COVID-19), pregnancy and women’s health (Royal College of Obstetricians and Gynaecologists)
Musculoskeletal system
- Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19 (NHSEI)
- Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (NICE, ES23)
- Disease modifying drugs: monitoring guidance (MLCSU)
- COVID-19: guidance for rheumatologists (British Society for Rheumatology)
Nervous system
- Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19 (NHSEI)
- Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (NICE, ES23)
- COVID-19 guidance and advice (Association of British Neurologists)
- Depot antipsychotic injections: Administration during COVID-19 in stable adult patients (MLCSU)
- Lithium for stable adult patients: monitoring guidance. (MLCSU)
- Valproate Pregnancy Prevention Programme: temporary advice for management during coronavirus (MHRA)
Nutrition and metabolic disorders
- Vitamin B12 replacement (MLCSU)
- Vitamin D and infection risk (RDTC guidance adopted by MLCSU)
Respiratory system
- Asthma and COPD - oral steroid or antibiotic 'rescue packs' and extra steroid inhalers (RDTC guidance adopted by MLCSU)
- Community-based care of patients with chronic obstructive pulmonary disease (COPD) (NICE, NG168)
- Coronavirus and COVID-19 (British Lung Foundation)
- COVID-19: information for the respiratory community (British Thoracic Society)
- Early use of antibiotics in high-risk patients (under review for MLCSU position)
- Health advice for people with asthma (Asthma UK)
- Managing symptoms (including at the end of life) in the community (NICE, NG163)
- Managing suspected or confirmed pneumonia in adults in the community (NICE, NG165)
- Prescribing for Asthma and COPD guidance (RDTC guidance adopted by MLCSU)
- Respiratory inhalers (BTS)
Skin
- Advice for Dermatology HCPs during Covid-19 pandemic (British Association of Dermatologists)
Therapeutic drug monitoring
- Disease modifying drugs: monitoring guidance. (MLCSU)
- Lithium for stable adult patients: monitoring guidance. (MLCSU)
- Management of patients currently on warfarin during COVID-19 (SPS guidance adopted by MLCSU)
- Monitoring direct acting oral anticoagulants (DOACs) during the COVID-19 pandemic (RDTC guidance adopted by MLCSU)
Prescribing guidance
Prescribing in children
- Clinical guidelines for children and young people with palliative care needs in all care settings during the COVID19 pandemic (NHSEI)
- COVID-19 rapid guideline: children and young people who are immunocompromised [NICE NG174]
- Hospital Communication Passport and Supporting Resources (Include Me TOO)
- Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (RCPCH)
Prescribing in palliative care
- Clinical guidelines for children and young people with palliative care needs in all care settings during the COVID19 pandemic (NHSEI > Secondary care > Speciality guides > Children)
- Collated list of resources for COVID-19 in palliative care (palliativedrugs.com)
Operational guidance
Care homes
- Bulk Prescribing for Care Homes: A Guide for Care Home Teams (NHS North West)
- Care Home and Hospice Homely Remedy Guidance during COVID-19 (NHS North West)
- Care Home Resource Hub (SPS)
- Coronavirus (COVID-19): support for care homes (DHSC)
- COVID-19 response: Identifying a clinical lead for all care homes (NHSEI)
- Medication Acquisition Guidance during COVID-19 for Care Homes with Nursing and Hospices (NHS North West)
- Medication Acquisition Guidance during COVID-19 for Care Homes without Nursing (NHS North West)
- Pharmacy and Medicines Support to Care Homes: Urgent System-Wide Delivery Model (SPS)
Community pharmacy
- COVID-19 practical guidance and FAQs (RPS)
- Electronic Repeat Dispensing (Wessex Academic Health Science Network adopted by MLCSU)
- Ethical, professional decision making in the COVID-19 Pandemic (RPS)
- Guidance for Manufacturers Specials licence holders on ‘packing down’ medicines during the coronavirus (COVID-19) outbreak (MHRA)
- Pandemic delivery service (PSNC)
- Primary care pharmacy during the COVID pandemic (Primary Care Pharmacy Association)
- Q&A: Coronavirus (GPhC)
- Volunteers Guidance (RPS)
Finance
- Clinical Negligence Scheme for Coronavirus (NHS Resolution > Claims management)
- Revised arrangements for NHS contracting and payment during the COVID-19 pandemic (NHSEI > Finance)
General practice
- Advice on how to establish a remote ‘total triage’ model in general practice using online consultations (NHSEI)
- COVID-19 (British Medical Association)
- Electronic Repeat Dispensing (Wessex Academic Health Science Network adopted by MLCSU)
- Information for GPs advising both shielding and non shielding patients on support available during the COVID 19 pandemic (NHSEI)
- Managing coronavirus (COVID-19) in general practice (SOP) (NHSEI)
- Notifiable diseases and causative organisms: how to report (PHE)
- Primary care and community health support care home residents (NHSEI)
- Primary care pharmacy during the COVID pandemic (Primary Care Pharmacy Association)
- Shielded patients list: guidance for General Practice (NHS Digital)
Workforce
- Advice regarding NHS volunteers relating to COVID-19 (NHSEI)
- Community Pharmacy Volunteers Guidance (RPS)
- COVID-19 and Ramadan (NHS People)
- COVID-19 Supporting Guidance for prescribers working within COVID hubs and Medicine Conveyance with GP bags (NHS North West)
- Organisational Prescribing Code and EPS Guide for Primary Care (NHS North West)
- Ramadan rapid review (British Islamic Medical Association)
- Risks Assessment and Considerations – for setting up COVID-19 Hubs (NHS North West)
- Stay at home: guidance for households with possible coronavirus (COVID-19) infection (PHE)
Other resources
- Coronavirus (COVID-19) hub (The BMJ)
- Coronavirus (COVID-19): reuse of medicines in a care home or hospice (NHSEI)
- Coronavirus guidance for clinicians and NHS managers (NHSEI)
- Coronavirus (COVID-19) (SPS)
- COVID-19 Supporting Guidance for prescribers working within COVID hubs and Medicine Conveyance with GP bags (NHS North West)
- MHRA regulatory flexibilities resulting from coronavirus (COVID-19)
- Our plan to rebuild: The UK Government’s COVID-19 recovery strategy (GOV.UK)
- Organisational Prescribing Code and EPS Guide for Primary Care (NHS North West)
- Risks Assessment and Considerations – for setting up COVID-19 Hubs (NHS North West)
- Specialty guides (NHSEI)
- Second phase of NHS response to COVID-19: Letter from Sir Simon Stevens and Amanda Pritchard (NHSEI)
- Specialty-specific guidance on clinical care and treatment for COVID-19 (Royal College of Physicians)
- Stay at home: guidance for households with possible coronavirus (COVID-19) infection (PHE)
- The Misuse of Drugs (Coronavirus) (Amendments Relating to the Supply of Controlled Drugs During a Pandemic etc.) Regulations 2020 (GOV.UK)